Finalists revealed for CPhI Pharma Awards

The finalists for the CPhI Pharma Awards at the forthcoming CPhI Worldwide event have been announced.

The shortlist spans thirteen different award categories covering the full spectrum of the pharmaceutical supply chain – including ‘Formulation’, ‘Packaging’ and ‘Lifetime Achievement Awards’.

The winners will be announced on November 5 at a ceremony in The Forum, Congress Centre Messe Frankfurt.

This year’s judging panel – comprised of independent, senior industry experts – have carefully selected the finalists from all the received entries.

Subsequently, the winners’ shortlist is packed with forty of the industry’s most innovative companies and individuals who are truly shaping the future of pharma.

Since 2003, the CPhI Pharma Awards, powered by Informa Pharma Intelligence have focused on recognising innovation in the pharmaceutical industry, applauding pharmaceutical and biopharmaceutical companies engaged in the design, development, manufacture, production and distribution of large and small molecule drug products.

This year, the formulation and packaging categories were the most competitive, with both accolades boasting seven finalists each.

“This year has been a truly ground-breaking year for innovation in the pharmaceutical industry as demonstrated by the quality of the entries for the CPhI Pharma Awards covering all parts of the pharmaceutical supply chain,” said Tara Dougal, Head of Content at Informa.

“The judges have tirelessly worked to ensure that all award submissions and their merits were thoroughly evaluated, and I’d like to thank them for all their efforts.

“Good luck to the finalists and I look forward to seeing many of them at the Awards ceremony on the opening day of CPhI Worldwide.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

4D pharma merges with SPAC in $37.6m deal

4D pharma, the listed Leeds-headquartered pharmaceutical company, has merged with Longevity, a special purpose acquisition company (SPAC), in a deal worth up to $37.6...

Cyted acquires Pathognomics Ltd to support expansion of digital pathology and diagnostic reporting services

Cyted Ltd, a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, has acquired Pathognomics Limited,...

Record quarter for UK biotech as £1bn is raised

UK biotech companies raised more than £1 billion in equity finance between June and August 2020, the highest quarter for investments in the sector...

Moderna regains rights to RSV vaccine from Merck

Moderna has regained all rights to the respiratory syncytial virus (RSV) vaccine (mRNA-1172) from Merck, including rights to develop RSV vaccines for adult populations. mRNA-1172,...

Takeda & Arrowhead to co-develop RNAi therapy for AATLD

Takeda and Arrowhead Pharmaceuticals will collaborate to develop ARO-AAT, a Phase 2 investigational RNA interference (RNAi) therapy in development to treat alpha-1 antitrypsin-associated liver...

Related news

CHMP recommends ViiV’s long-acting regimen for HIV

The Committee for Medicinal Products for Human Use (CHMP) has recommended ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) in combination with Rekambys (rilpivirine injection)...

4D pharma merges with SPAC in $37.6m deal

4D pharma, the listed Leeds-headquartered pharmaceutical company, has merged with Longevity, a special purpose acquisition company (SPAC), in a deal worth up to $37.6...

Cyted acquires Pathognomics Ltd to support expansion of digital pathology and diagnostic reporting services

Cyted Ltd, a developer and provider of artificial intelligence technology and digital diagnostic infrastructure to enable earlier detection of disease, has acquired Pathognomics Limited,...

Record quarter for UK biotech as £1bn is raised

UK biotech companies raised more than £1 billion in equity finance between June and August 2020, the highest quarter for investments in the sector...